ATE485281T1 - Triazinderivate und deren verwendung als sonnenschutzmittel - Google Patents

Triazinderivate und deren verwendung als sonnenschutzmittel

Info

Publication number
ATE485281T1
ATE485281T1 AT02772133T AT02772133T ATE485281T1 AT E485281 T1 ATE485281 T1 AT E485281T1 AT 02772133 T AT02772133 T AT 02772133T AT 02772133 T AT02772133 T AT 02772133T AT E485281 T1 ATE485281 T1 AT E485281T1
Authority
AT
Austria
Prior art keywords
sub
alkyl
unsubstituted
substituted
alkoxy
Prior art date
Application number
AT02772133T
Other languages
German (de)
English (en)
Inventor
Barbara Wagner
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Application granted granted Critical
Publication of ATE485281T1 publication Critical patent/ATE485281T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02772133T 2001-08-17 2002-08-08 Triazinderivate und deren verwendung als sonnenschutzmittel ATE485281T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01810796 2001-08-17
CH16992001 2001-09-14
PCT/EP2002/008888 WO2003016289A1 (en) 2001-08-17 2002-08-08 Triazine derivatives and their use as sunscreens

Publications (1)

Publication Number Publication Date
ATE485281T1 true ATE485281T1 (de) 2010-11-15

Family

ID=25739004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02772133T ATE485281T1 (de) 2001-08-17 2002-08-08 Triazinderivate und deren verwendung als sonnenschutzmittel

Country Status (7)

Country Link
US (1) US7038046B2 (https=)
EP (1) EP1423371B1 (https=)
JP (1) JP4344241B2 (https=)
AT (1) ATE485281T1 (https=)
DE (1) DE60238066D1 (https=)
DK (1) DK1423371T3 (https=)
WO (1) WO2003016289A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6748471B1 (en) * 2000-10-16 2004-06-08 Electronics For Imaging, Inc. Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer
US7574545B2 (en) * 2000-10-16 2009-08-11 Electronics For Imaging, Inc. Method and apparatus for controlling a document output device with a control request stored at a server
FR2867188A1 (fr) * 2004-03-03 2005-09-09 Oreal Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri
US20070286827A1 (en) * 2006-06-12 2007-12-13 Esschem, Inc. Optical brighter and uv stabilizer for acrylic enhancements
EP2037746A4 (en) * 2006-06-29 2010-09-22 Martek Biosciences Corp GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR
AU2007287653B2 (en) * 2006-08-23 2011-02-03 Unilever Plc Photostable cosmetic compositions
US20080096782A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials
US20080097070A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous polyamine-containing systems for water-insoluble materials
US20120121515A1 (en) 2009-03-13 2012-05-17 Lenny Dang Methods and compositions for cell-proliferation-related disorders
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
WO2011050210A1 (en) 2009-10-21 2011-04-28 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
AU2011250962B2 (en) 2010-05-10 2015-09-03 Gfbiochemicals Limited Personal care formulations containing alkyl ketal esters and methods of manufacture
KR101856808B1 (ko) 2010-12-28 2018-05-10 닛산 가가쿠 고교 가부시키 가이샤 폴리이미드막 형성용 도포액, 액정 배향제, 폴리이미드막, 액정 배향막 및 액정 표시 소자
WO2012092546A2 (en) * 2010-12-30 2012-07-05 L'oreal S.A. Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax
SMT202400081T1 (it) 2011-05-03 2024-03-13 Agios Pharmaceuticals Inc Attivatori della piruvato chinasi per uso in terapia
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
PE20142098A1 (es) 2012-01-06 2015-01-08 Agios Pharmaceuticals Inc Compuestos terapeuticamente activos y sus metodos de uso
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
EP2906212A4 (en) 2012-10-15 2016-06-08 Agios Pharmaceuticals Inc THERAPEUTIC COMPOUNDS AND COMPOSITIONS
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
AU2014287122B9 (en) 2013-07-11 2018-11-01 Les Laboratoires Servier N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
CN105593215B (zh) 2013-07-11 2019-01-15 安吉奥斯医药品有限公司 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015010297A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
NZ723859A (en) 2014-03-14 2023-01-27 Servier Lab Pharmaceutical compositions of therapeutically active compounds and their uses
CA2989111C (en) 2015-06-11 2023-10-03 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
KR102699521B1 (ko) 2015-10-15 2024-08-26 르 라보레또레 쎄르비에르 악성 종양의 치료를 위한 조합물 요법
FI3362065T3 (fi) 2015-10-15 2024-06-19 Servier Lab Ivosidenibiä, sytarabiinia ja daunorubisiinia tai idarubisiinia käsittävä yhdistelmähoito akuutin myelooisen leukemian hoitamiseksi
CN107827764A (zh) * 2017-11-27 2018-03-23 上海应用技术大学 一种双β‑氨基酮或双β‑氨基酯类的制备方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4105923A1 (de) 1991-02-26 1992-08-27 Basf Ag P-aminozimtsaeure-substituierte triazine
DE4223890A1 (de) * 1992-02-19 1993-08-26 Merck Patent Gmbh Triazin-derivate
FR2744721B1 (fr) * 1996-02-12 1999-06-18 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations

Also Published As

Publication number Publication date
JP4344241B2 (ja) 2009-10-14
DK1423371T3 (da) 2011-02-07
EP1423371A1 (en) 2004-06-02
US20040242579A1 (en) 2004-12-02
DE60238066D1 (de) 2010-12-02
WO2003016289A1 (en) 2003-02-27
EP1423371B1 (en) 2010-10-20
JP2005501855A (ja) 2005-01-20
US7038046B2 (en) 2006-05-02

Similar Documents

Publication Publication Date Title
ATE485281T1 (de) Triazinderivate und deren verwendung als sonnenschutzmittel
DK0671161T3 (da) Ectoin og ectoinderivater som fugtighedsgiver i kosmetikprodukter
JP2005538072A5 (https=)
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
HUP0004259A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények
ZA200401461B (en) Heterocyclic compound based on n6 substituted adenine methods of their preparation their use for preparation of drugs cosmetic preparations and growth regulators pharmaceutical prepartion cosmetic preparations and growth regulators containing these compou
HUP0003929A2 (hu) Piperazinszármazékok és alkalmazásuk gyulladásgátló hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények
HUP0402352A2 (hu) Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
AR036107A1 (es) Derivados de 6-fenilpirrolpirimidindiona, antagonista de los receptores a2 de la adenosina, particularmente del subtipo a2, de aplicacion en la prevencion de la degranulacion de los mastocitos; composiciones farmaceuticas formuladas con dichos compuestos y uso de los mismos en la preparacion de medi
JP2005501855A5 (https=)
DE69720535D1 (de) Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon
DK0585155T3 (da) Trifluormethylketon-peptidderivater med HLE-inhiberende aktivitet, deres fremstilling og farmaceutiske præparater
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
AR030424A1 (es) Derivados de 6-fenilpirrol[3,2-d] pirimidina y de 6-fenilpirrol[2,3-d]-pirimidin-2,4-diona; procedimientos de preparacion de dichos derivados; compuestos intermediarios de aplicacion en la preparacion de dichos derivados y el uso de los mismos en el tratamiento del cuerpo humano y/o de animales y/o
NO20000313L (no) Nye forbindelser
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
ES2104952T3 (es) Derivados de nitroanilina y su uso como agentes antitumorales.
NZ330078A (en) Active oxygen carriers containing pterin derivatives and salts thereof for use as cosmetic agents and feed
AR024904A1 (es) Derivados de pirrol heteroaril sustituidos, su preparacion y sus usos terapeuticos.
ATE131030T1 (de) Indolin-produkte, ihren verfahren zu deren herstellung sowie ihren verwendung in der kosmetik.
EP0321968A3 (en) Compounds active on the cardiovascular system
HUP0303204A2 (hu) 1-Metilkarbapenem-származékok és ezeket tartalmazó gyógyszerkészítmények
BR0309308A (pt) Compostos de aminofenilbenzotiazol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties